Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S ADR (NY: NVO )

103.50 -2.84 (-2.67%)
Official Closing Price Updated: 7:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 992,240
Open 104.63
Bid (Size) 103.10 (1)
Ask (Size) 103.65 (1)
Prev. Close 106.34
Today's Range 103.12 - 105.08
52wk Range 78.71 - 122.16
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Top-Rated Eli Lilly Nears Breakout After FDA Approves Its Next Potential Blockbuster
The Food and Drug Administration approved an Eli Lilly diabetes drug it described as "novel," prodding LLY stock closer to a breakout. 
Via Investor's Business Daily
7 Profitable Places to Hide Your Money During a Bear Market
With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification. 
Via InvestorPlace

Performance

YTD
-4.86%
-4.86%
1 Month
-11.06%
-11.06%
3 Month
+2.11%
+2.11%
6 Month
-9.20%
-9.20%
1 Year
+28.44%
+28.44%

More News

Read More
Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices
Via Benzinga
Why Novo Nordisk Shares Are Trading Higher Today
Via Benzinga
Ascendis Slammed After Growth Hormone Drug Faces An Unexpected Challenge
Via Investor's Business Daily
Heart Failure Treatment Offers Hope to Diabetics
Via FinancialNewsMedia
Peering Into Novo Nordisk's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
Via Benzinga
Bulls Try To Build On Yesterday's Gains But Looming Fed Decision Could Curb Trading
Via Benzinga
Disappointing Earnings And A Spike In Inflation Send Stocks Plunging
Via Benzinga
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
Via Investor's Business Daily
Novo Nordisk's Once-Weekly Insulin Icodec Shows Favorable Reduction In HbA1c In Type 2 Diabetes
Via Benzinga
Surprise Negative GDP Report Could Hurt Premarket Rally
Via Benzinga
The S&P 500 And Nasdaq Testing Major Support Levels
Via Benzinga
Nasdaq Loses Nearly 4%, Techs Reel As Global, Fed, And Earnings Fears Mount
Via Benzinga
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 5 Years
Via Benzinga
24 Biggest Movers From Yesterday
Via Benzinga
If You Invested $100 In Novo Nordisk 10 Years Ago, Here's How Much You Would Have Today
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ
Via Benzinga
House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
Via Benzinga
$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much
Via Benzinga
Aeterna Zentaris Says Enrollment In Growth Hormone Deficiency Trial To Continue Into 2023
Via Benzinga
66 Firms Going Ex-Dividend Next Week, Including Philip Morris, Medtronic & Sempra Energy
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.